Vimkunya
What Vimkunya is used for
Vimkunya is indicated for active immunisation for the prevention of disease caused by chikungunya virus (CHIKV) in individuals 12 years and older. The use of this vaccine should be in accordance with official recommendations.
Approved use, as published by the European Medicines Agency.
What the labels mean
- PRIME: a priority medicine that the EMA supported early because it may meet an unmet need.
Key facts
- Brand
- Vimkunya
- Active substance
- Chikungunya vaccine (recombinant, adsorbed)
- Disease area
- Chikungunya virus
- Marketing authorisation holder
- Bavarian Nordic A/S
- Authorised in the EU since
- 2025
Official information
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Vimkunya used for?
Vimkunya is indicated for active immunisation for the prevention of disease caused by chikungunya virus (CHIKV) in individuals 12 years and older. The use of this vaccine should be in accordance with official recommendations.
What is the active substance in Vimkunya?
Vimkunya contains Chikungunya vaccine (recombinant, adsorbed).
Who makes Vimkunya?
The EU marketing authorisation holder is Bavarian Nordic A/S.
Source: European Medicines Agency medicines data (ema.europa.eu), reproduced with acknowledgement of the source. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, EU